Delivery Order SPE2DB24D3013-SPE2DB25FFNDE
Award Date 7/3/25
Potential Completion Date 7/7/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,624.40 firm fixed-price delivery order is for the supply of XHANCE 93 MCG Nasal Spray 16ML, a pharmaceutical product. The contract has an ultimate completion date of December 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XHANCE 93 MCG NASAL SPRAY 16ML, a medical product. The contract has a ceiling value of $4,739.56 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,436.26, is for the delivery of XHANCE 93 MCG Nasal Spray 16ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of December 18, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of XHANCE 93 MCG Nasal Spray 16ML. The $4,796.97 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a wide range of medical commodities to support military treatment programs...
- This federal contract award is for the delivery of XHANCE 93 MCG NASAL SPRAY 16ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,018.98 and is a Delivery Order with a Firm Fixed Price pricing type. The ultimate completion date is December 18, 2024. This contract is not designated with a set-aside requirement,...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product XHANCE 93 MCG NASAL SPRAY 16ML. The contract has a ceiling value of $1,026.39 and a period of performance through April 15, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA that serves as the primary vehicle for the company to deliver...
- This federal contract award, with ID SPE2DB20D2104|SPE2DB24FMASB, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,313.67 Firm Fixed Price contract is for the delivery of XHANCE 93 MCG Nasal Spray 16ML, with a completion date of September 4, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,691.13 firm fixed-price delivery order contract is for the supply of XHANCE 93 MCG NASAL SPRAY 16ML to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is not designated with a set-aside requirement, indicating open competition....
- The Defense Logistics Agency awarded a $4,033.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XHANCE 93 micrograms nasal spray (16 milliliters) on August 20, 2025, with completion scheduled for August 21, 2025. This non-set-aside award was issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order represents a routine...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the pharmaceutical product XHANCE 93 MCG NASAL SPRAY 16ML. The firm-fixed-price contract has a ceiling value of $1,222.86 and a period of performance through July 14, 2023. There is no set-aside designation on this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA...